These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21277831)
1. Outcome of continence procedures after failed endoscopic treatment with dextranomer-based implants (DEFLUX®). Alova I; Margaryan M; Verkarre V; Bernuy M; Lortat Jacob S; Lottmann HB J Pediatr Urol; 2012 Feb; 8(1):40-6. PubMed ID: 21277831 [TBL] [Abstract][Full Text] [Related]
2. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [TBL] [Abstract][Full Text] [Related]
3. Endoscopic injection of bulking agents in children with incontinence: dextranomer/hyaluronic acid copolymer versus polytetrafluoroethylene. Dyer L; Franco I; Firlit CF; Reda EF; Levitt SB; Palmer LS J Urol; 2007 Oct; 178(4 Pt 2):1628-31. PubMed ID: 17707036 [TBL] [Abstract][Full Text] [Related]
4. Comparing the bulking effect of calcium hydroxyapatite and Deflux injection into the bladder neck for improvement of urinary incontinence in bladder exstrophy-epispadias complex. Eftekharzadeh S; Sabetkish N; Sabetkish S; Kajbafzadeh AM Int Urol Nephrol; 2017 Feb; 49(2):183-189. PubMed ID: 27896576 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of dextranomer endoscopic injections for treatment of urinary incontinence: an update of a prospective study of 31 patients. Lottmann HB; Margaryan M; Bernuy M; Grosz A; Aigrain Y; Lortat-Jacob S; Läckgren G J Urol; 2006 Apr; 175(4):1485-9. PubMed ID: 16516030 [TBL] [Abstract][Full Text] [Related]
6. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Lightner DJ; Fox J; Klingele C Urology; 2010 Jun; 75(6):1310-4. PubMed ID: 20299087 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of endoscopic injection of dextranomer/hyaluronic acid based implants for treatment of urinary incontinence in children with neurogenic bladder. Alova I; Margaryan M; Bernuy M; Lortat-Jacob S; Lottmann HB J Urol; 2012 Nov; 188(5):1905-9. PubMed ID: 22998918 [TBL] [Abstract][Full Text] [Related]
8. Dextranomer Endoscopic Injections for the Treatment of Urinary Incontinence in Bladder Exstrophy-epispadias Complex. Fiorenza V; Hukkinen M; Alova I; Clermidi P; Broch A; Botto N; Blanc T; Lottmann HB J Urol; 2023 Mar; 209(3):591-599. PubMed ID: 36449491 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of dextranomer endoscopic injections for the treatment of urinary incontinence: an update of a prospective study of 61 patients. Lottmann HB; Margaryan M; Lortat-Jacob S; Bernuy M; Läckgren G J Urol; 2006 Oct; 176(4 Pt 2):1762-6. PubMed ID: 16945642 [TBL] [Abstract][Full Text] [Related]
10. Does intraoperative success predict outcome in the treatment of urethral sphincter insufficiency with bulking agent? Pakkasjärvi N; Taskinen S J Pediatr Urol; 2018 Apr; 14(2):173.e1-173.e5. PubMed ID: 29398585 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic treatment of urinary incontinence in pediatric patients: 2-year experience with dextranomer/hyaluronic acid copolymer. Caione P; Capozza N J Urol; 2002 Oct; 168(4 Pt 2):1868-71. PubMed ID: 12352378 [TBL] [Abstract][Full Text] [Related]
12. The effect of endoscopic injections of dextranomer based implants on continence and bladder capacity: a prospective study of 31 patients. Lottmann HB; Margaryan M; Bernuy M; Rouffet MJ; Bau MO; El-Ghoneimi A; Aigrain Y; Stenberg A; Läckgren G J Urol; 2002 Oct; 168(4 Pt 2):1863-7; discussion 1867. PubMed ID: 12352377 [TBL] [Abstract][Full Text] [Related]
13. Modified bladder neck reconstruction in patients with incontinence after staged exstrophy/epispadias closures. DeCambre M; Casale P; Grady R; Swartz M; Mitchell M J Urol; 2006 Jul; 176(1):288-91. PubMed ID: 16753424 [TBL] [Abstract][Full Text] [Related]
14. Long-term results of bulking agent injection for persistent incontinence in cases of neurogenic bladder dysfunction. De Vocht TF; Chrzan R; Dik P; Klijn AJ; De Jong TP J Urol; 2010 Feb; 183(2):719-23. PubMed ID: 20022056 [TBL] [Abstract][Full Text] [Related]
15. Incontinence following bladder neck reconstruction--is there a role for endoscopic management? Kitchens DM; Minevich E; DeFoor WR; Reddy PP; Wacksman J; Koyle MA; Sheldon CA J Urol; 2007 Jan; 177(1):302-5; discussion 305-6. PubMed ID: 17162070 [TBL] [Abstract][Full Text] [Related]
16. Asymptomatic chronic partial obstruction of a normal ureter following dextranomer/hyaluronic acid copolymer (Deflux®) injection for grade I vesicoureteral reflux. Arlen AM; Pakalniskis BL; Cooper CS J Pediatr Urol; 2012 Jun; 8(3):e27-30. PubMed ID: 22209086 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic treatment of vesico-ureteric reflux and urinary incontinence: technical problems in the paediatric patient. Capozza N; Caione P; De Gennaro M; Nappo S; Patricolo M Br J Urol; 1995 Apr; 75(4):538-42. PubMed ID: 7788267 [TBL] [Abstract][Full Text] [Related]